Homocysteine induces serum amyloid A3 in osteoblasts via unlocking RGD-motifs in collagen

FASEB Journal

Volumn 27, Issue 2, 2013, Pages 446-463

  Thaler, Roman ^a   Zwerina, Jochen ^a   Rumpler, Monika ^a   Spitzer, Silvia ^a   Gamsjaeger, Sonja ^a   Paschalis, Eleftherios P ^a   Klaushofer, Klaus ^a   Varga, Franz ^a  

^a HANUSCH HOSPITAL   (Austria)

Author keywords

Bone; Extracellular matrix; MC3T3 E1 cells; Saa3

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BETA CATENIN; COLLAGEN; COLLAGENASE 3; FOCAL ADHESION KINASE 1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HOMOCYSTEINE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PAXILLIN; RANTES; SERUM AMYLOID A; SERUM AMYLOID A3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE METABOLISM; CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CROSS LINKING; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; INFRARED SPECTROSCOPY; MOUSE; MULTIGENE FAMILY; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; ANTIGENS, CD95; BASE SEQUENCE; BETA CATENIN; CELL LINE; CHEMOKINE CCL5; COLLAGEN TYPE I; EXTRACELLULAR MATRIX; FOCAL ADHESION KINASE 1; GENE EXPRESSION; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MATRIX METALLOPROTEINASE 13; MICE; MODELS, BIOLOGICAL; OLIGOPEPTIDES; OSTEOBLASTS; OSTEOPOROSIS; PAXILLIN; PROTEIN DENATURATION; RNA, MESSENGER; RNA, SMALL INTERFERING; SERUM AMYLOID A PROTEIN; SIGNAL TRANSDUCTION;

EID: 84873416224     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-208058     Document Type: Article

References (72)

1. Lian, J. B., Stein, G. S., Javed, A., van Wijnen, A. J., Stein, J. L., Montecino, M., Hassan, M. Q., Gaur, T., Lengner, C. J., and Young, D. W. (2006) Networks and hubs for the transcriptional control of osteoblastogenesis. Rev. Endocr. Metab. Disord. 7, 1-16
2. Sudo, H., Kodama, H. A., Amagai, Y., Yamamoto, S., and Kasai, S. (1983) In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell Biol. 96, 191-198
3. Fratzl-Zelman, N., Glantschnig, H., Rumpler, M., Nader, A., Ellinger, A., and Varga, F. (2003) The expression of matrix metalloproteinase-13 and osteocalcin in mouse osteoblasts is related to osteoblastic differentiation and is modulated by 1,25-dihydroxyvitamin D3 and thyroid hormones. Cell Biol. Int. 27, 459-468
4. Thaler, R., Agsten, M., Spitzer, S., Paschalis, E. P., Karlic, H., Klaushofer, K., and Varga, F. (2011) Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1, and epigenetic DNA methylation. J. Biol. Chem. 286, 5578-5588
5. Taubenberger, A. V., Woodruff, M. A., Bai, H., Muller, D. J., and Hutmacher, D. W. (2010) The effect of unlocking RGD-motifs in collagen I on pre-osteoblast adhesion and differentiation. Biomaterials 31, 2827-2835
6. Mauney, J. R., Kirker-Head, C., Abrahamson, L., Gronowicz, G., Volloch, V., and Kaplan, D. L. (2006) Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. J. Biomed. Mater. Res. A 79, 464-475
7. Blouin, S., Thaler, H. W., Korninger, C., Schmid, R., Hofstaetter, J. G., Zoehrer, R., Phipps, R., Klaushofer, K., Roschger, P., and Paschalis, E. P. (2009) Bone matrix quality and plasma homocysteine levels. Bone 44, 959-964
8. Kagan, H. M., and Li, W. (2003) Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J. Cell. Biochem. 88, 660-672
9. Brustolin, S., Giugliani, R., and Felix, T. M. (2010) Genetics of homocysteine metabolism and associated disorders. Braz. J. Med. Biol. Res. 43, 1-7
10. Villa, P., Suriano, R., Costantini, B., Macri, F., Ricciardi, L., Campagna, G., and Lanzone, A. (2007) Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation. Clin. Chem. Lab. Med. 45, 130-135
11. Dionisio, N., Jardin, I., Salido, G. M., and Rosado, J. A. (2010) Homocysteine, intracellular signaling and thrombotic disorders. Curr. Med. Chem. 17, 3109-3119
12. Van Dam, F., and Van Gool, W. A. (2009) Hyperhomocysteinemia and Alzheimer's disease: A systematic review. Arch. Gerontol. Geriatr. 48, 425-430
13. Raisz, L. G. (2004) Homocysteine and osteoporotic fractures-culprit or bystanderN. Engl. J. Med. 350, 2089-2090
14. Gjesdal, C. G., Vollset, S. E., Ueland, P. M., Refsum, H., Meyer, H. E., and Tell, G. S. (2007) Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: the hordaland homocysteine study. J. Bone Miner. Res. 22, 747-756
15. McLean, R. R., Jacques, P. F., Selhub, J., Tucker, K. L., Samelson, E. J., Broe, K. E., Hannan, M. T., Cupples, L. A., and Kiel, D. P. (2004) Homocysteine as a predictive factor for hip fracture in older persons. N. Engl. J. Med. 350, 2042-2049
16. Uhlar, C. M., and Whitehead, A. S. (1999) Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265, 501-523
17. Meek, R. L., Eriksen, N., and Benditt, E. P. (1992) Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. Proc. Natl. Acad. Sci. U. S. A. 89, 7949-7952
18. Vallon, R., Freuler, F., Desta-Tsedu, N., Robeva, A., Dawson, J., Wenner, P., Engelhardt, P., Boes, L., Schnyder, J., Tschopp, C., Urfer, R., and Baumann, G. (2001) Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J. Immunol. 166, 2801-2807
19. Malle, E., and De Beer, F. C. (1996) Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur. J. Clin. Invest. 26, 427-435
20. Kumon, Y., Loose, L. D., Birbara, C. A., and Sipe, J. D. (1997) Rheumatoid arthritis exhibits reduced acute phase and enhanced constitutive serum amyloid A protein in synovial fluid relative to serum. A comparison with C-reactive protein. J. Rheumatol. 24, 14-19
21. Meek, R. L., and Benditt, E. P. (1986) Amyloid A gene family expression in different mouse tissues. J. Exp. Med. 164, 2006-2017
22. Chiba, T., Han, C. Y., Vaisar, T., Shimokado, K., Kargi, A., Chen, M. H., Wang, S., McDonald, T. O., O'Brien, K. D., Heinecke, J. W., and Chait, A. (2009) Serum amyloid A3 does not contribute to circulating SAA levels. J. Lipid Res. 50, 1353-1362
23. Thorn, C. F., Lu, Z. Y., and Whitehead, A. S. (2003) Tissuespecific regulation of the human acute-phase serum amyloid A genes, SAA1 and SAA2, by glucocorticoids in hepatic and epithelial cells. Eur. J. Immunol. 33, 2630-2639
24. Rygg, M., Nordstoga, K., Husby, G., and Marhaug, G. (1993) Expression of serum amyloid A genes in mink during induction of inflammation and amyloidosis. Biochim. Biophys. Acta 1216, 402-408
25. Subramanian, S., Han, C. Y., Chiba, T., McMillen, T. S., Wang, S. A., Haw, A., 3rd, Kirk, E. A., O'Brien, K. D., and Chait, A. (2008) Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 28, 685-691
26. Zerega, B., Pagano, A., Pianezzi, A., Ulivi, V., Camardella, L., Cancedda, R., and Cancedda, F. D. (2004) Expression of serum amyloid A in chondrocytes and myoblasts differentiation and inflammation: possible role in cholesterol homeostasis. Matrix Biol. 23, 35-46
27. Maier, W., Altwegg, L. A., Corti, R., Gay, S., Hersberger, M., Maly, F. E., Sutsch, G., Roffi, M., Neidhart, M., Eberli, F. R., Tanner, F. C., Gobbi, S., von Eckardstein, A., and Luscher, T. F. (2005) Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 111, 1355-1361
28. Yamada, T., Wada, A., Itoh, K., and Igari, J. (2000) Serum amyloid A secretion from monocytic leukaemia cell line THP-1 and cultured human peripheral monocytes. Scand. J. Immunol. 52, 7-12
29. Reigstad, C. S., Lunden, G. O., Felin, J., and Backhed, F. (2009) Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota. PLoS One 4, e5842
30. Sommer, G., Weise, S., Kralisch, S., Scherer, P. E., Lossner, U., Bluher, M., Stumvoll, M., and Fasshauer, M. (2008) The adipokine SAA3 is induced by interleukin-1beta in mouse adipocytes. J. Cell. Biochem. 104, 2241-2247
31. Fasshauer, M., Klein, J., Kralisch, S., Klier, M., Lossner, U., Bluher, M., and Paschke, R. (2004) Serum amyloid A3 expression is stimulated by dexamethasone and interleukin-6 in 3T3-L1 adipocytes. J. Endocrinol. 183, 561-567
32. Ludlage, E., Murphy, C. L., Davern, S. M., Solomon, A., Weiss, D. T., Glenn-Smith, D., Dworkin, S., and Mansfield, K. G. (2005) Systemic AA amyloidosis in the common marmoset. Vet. Pathol. 42, 117-124
33. Peperkamp, N. H., Landman, W. J., Tooten, P. C., Ultee, A., Voorhout, W. F., and Gruys, E. (1997) Light microscopic, immunohistochemical, and electron microscopic features of amyloid arthropathy in chickens. Vet. Pathol. 34, 271-278
34. Gruys, E., Tooten, P. C., and Kuijpers, M. H. (1996) Lung, ileum and heart are predilection sites for AApoAII amyloid deposition in CD-1 Swiss mice used for toxicity studies. Pulmonary amyloid indicates AApoAII. Lab. Anim. 30, 28-34
35. Westermark, G. T., Sletten, K., Grubb, A., and Westermark, P. (1990) AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product. Am. J. Pathol. 137, 377-383
36. Katayama, T., Nakashima, H., Honda, Y., Suzuki, S., Yamamoto, T., Iwasaki, Y., and Yano, K. (2007) The relationship between acute phase serum amyloid A (SAA) protein concentrations and left ventricular systolic function in acute myocardial infarction patients treated with primary coronary angioplasty. Int. Heart. J. 48, 45-55
37. Johnson, B. D., Kip, K. E., Marroquin, O. C., Ridker, P. M., Kelsey, S. F., Shaw, L. J., Pepine, C. J., Sharaf, B., Bairey Merz, C. N., Sopko, G., Olson, M. B., and Reis, S. E. (2004) Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109, 726-732
38. Lewis, K. E., Kirk, E. A., McDonald, T. O., Wang, S., Wight, T. N., O'Brien, K. D., and Chait, A. (2004) Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice. Circulation 110, 540-545
39. Cunnane, G. (2001) Amyloid precursors and amyloidosis in inflammatory arthritis. Curr. Opin. Rheumatol. 13, 67-73
40. Chung, T. F., Sipe, J. D., McKee, A., Fine, R. E., Schreiber, B. M., Liang, J. S., and Johnson, R. J. (2000) Serum amyloid A in Alzheimer's disease brain is predominantly localized to myelin sheaths and axonal membrane. Amyloid 7, 105-110
41. Connolly, M., Veale, D. J., and Fearon, U. (2011) Acute serum amyloid A regulates cytoskeletal rearrangement, cell matrix interactions and promotes cell migration in rheumatoid arthritis. Ann. Rheum. Dis. 70, 1296-1303
42. Scheja, L., Heese, B., Zitzer, H., Michael, M. D., Siesky, A. M., Pospisil, H., Beisiegel, U., and Seedorf, K. (2008) Acute-phase serum amyloid A as a marker of insulin resistance in mice. Exp. Diabetes. Res. 2008:230837
43. Inada, M., Wang, Y., Byrne, M. H., Rahman, M. U., Miyaura, C., Lopez-Otin, C., and Krane, S. M. (2004) Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc. Natl. Acad. Sci. U. S. A. 101, 17192-17197
44. Kovacevic, A., Hammer, A., Stadelmeyer, E., Windischhofer, W., Sundl, M., Ray, A., Schweighofer, N., Friedl, G., Windhager, R., Sattler, W., and Malle, E. (2008) Expression of serum amyloid A transcripts in human bone tissues, differentiated osteoblast-like stem cells and human osteosarcoma cell lines. J. Cell. Biochem. 103, 994-1004
45. Biran, H., Friedman, N., Neumann, L., Pras, M., and Shainkin-Kestenbaum, R. (1986) Serum amyloid A (SAA) variations in patients with cancer: correlation with disease activity, stage, primary site, and prognosis. J. Clin. Pathol. 39, 794-797
46. Li, Y., Dang, T. A., Shen, J., Perlaky, L., Hicks, J., Murray, J., Meyer, W., Chintagumpala, M., Lau, C. C., and Man, T. K. (2006) Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma. Proteomics 6, 3426-3435
47. Morrison, C., Mancini, S., Cipollone, J., Kappelhoff, R., Roskelley, C., and Overall, C. (2011) Microarray and proteomic analysis of breast cancer cell and osteoblast co-cultures: role of osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis. J. Biol. Chem. 286, 34271-34285
48. Zhang, H., Sun, L., Wang, W., and Ma, X. (2006) Quantitative analysis of fibrosis formation on the microcapsule surface with the use of picro-sirius red staining, polarized light microscopy, and digital image analysis. J. Biomed. Mater. Res. A. 76, 120-125
49. Paschalis, E. P., Verdelis, K., Doty, S. B., Boskey, A. L., Mendelsohn, R., and Yamauchi, M. (2001) Spectroscopic characterization of collagen cross-links in bone. J. Bone Miner. Res. 16, 1821-1828
50. Pfaffl, M. W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45
51. Wu, X., Tu, X., Joeng, K. S., Hilton, M. J., Williams, D. A., and Long, F. (2008) Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. Cell 133, 340-353
52. Thaler, R., Spitzer, S., Rumpler, M., Fratzl-Zelman, N., Klaushofer, K., Paschalis, E. P., and Varga, F. (2010) Differential effects of homocysteine and beta aminopropionitrile on preosteoblastic MC3T3-E1 cells. Bone 46, 703-709
53. Kelley, B. P., Malfait, F., Bonafe, L., Baldridge, D., Homan, E., Symoens, S., Willaert, A., Elcioglu, N., Van Maldergem, L., Verellen-Dumoulin, C., Gillerot, Y., Napierala, D., Krakow, D., Beighton, P., Superti-Furga, A., De Paepe, A., and Lee, B. (2011) Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome. J. Bone Miner. Res. 26, 666-672
54. Rucker, R. B., Kosonen, T., Clegg, M. S., Mitchell, A. E., Rucker, B. R., Uriu-Hare, J. Y., and Keen, C. L. (1998) Copper, lysyl oxidase, and extracellular matrix protein cross-linking. Am. J. Clin. Nutr. 67, 996S-1002S
55. Mitra, S. K., and Schlaepfer, D. D. (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr. Opin. Cell Biol. 18, 516-523
56. Daugherty, R. L., and Gottardi, C. J. (2007) Phospho-regulation ofcatenin adhesion and signaling functions. Physiology 22, 303-309
57. Fornoni, A., Pileggi, A., Molano, R. D., Sanabria, N. Y., Tejada, T., Gonzalez-Quintana, J., Ichii, H., Inverardi, L., Ricordi, C., and Pastori, R. L. (2008) Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation. Diabetologia 51, 298-308
58. Dominguez, I., and Green, J. B. (2001) Missing links in GSK3 regulation. Dev. Biol. 235, 303-313
59. Moran, A. E., Carothers, A. M., Weyant, M. J., Redston, M., and Bertagnolli, M. M. (2005) Carnosol inhibits beta-catenin tyrosine phosphorylation and prevents adenoma formation in the C57BL/6J/Min/-(Min/-) mouse. Cancer Res. 65, 1097-1104
60. Kim, K., and Lee, K. Y. (2001) Tyrosine phosphorylation translocatescatenin from cell¡cell interface to the cytoplasm, but does not significantly enhance the LEF-1-dependent transactivating function. Cell Biol. Int. 25, 421-427
61. Rauner, M., Stein, N., Winzer, M., Goettsch, C., Zwerina, J., Schett, G., Distler, J. H., Albers, J., Schulze, J., Schinke, T., Bornhauser, M., Platzbecker, U., and Hofbauer, L. C. (2012) WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production. J. Bone Miner. Res. 27, 575-585
62. Liu, Y. C., Lai, W. C., Chuang, K. A., Shen, Y. J., Hu, W. S., Ho, C. H., Chen, Y. B., Hsu, M. F., Hsu, H. C., and Lieu, C. H. (2010) Blockade of JAK2 activity suppressed accumulation ofcatenin in leukemic cells. J. Cell. Biochem. 111, 402-411
63. Shimizu, H., and Yamamoto, K. (1994) NFB and C/EBP transcription factor families synergistically function in mouse serum amyloid A gene expression induced by inflammatory cytokines. Gene 149, 305-310
64. Li, X. X., and Liao, W. S. (1991) Expression of rat serum amyloid A1 gene involves both C/EBP-like and NFB-like transcription factors. J. Biol. Chem. 266, 15192-15201
65. Zhang, B., Une, Y., Ge, F., Fu, X., Qian, J., Zhang, P., Sawashita, J., Higuchi, K., and Mori, M. (2008) Characterization of the cheetah serum amyloid A1 gene: critical role and functional polymorphism of a cis-acting element. J. Hered. 99, 355-363
66. Marzocco, S., Piacente, S., Pizza, C., Oleszek, W., Stochmal, A., Pinto, A., Sorrentino, R., and Autore, G. (2004) Inhibition of inducible nitric oxide synthase expression by yuccaol C from Yucca schidigera roezl. Life Sci. 75, 1491-1501
67. Robich, M. P., Osipov, R. M., Nezafat, R., Feng, J., Clements, R. T., Bianchi, C., Boodhwani, M., Coady, M. A., Laham, R. J., and Sellke, F. W. (2010) Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia. Circulation 122, S142-149
68. Sun, S. C., and Ley, S. C. (2008) New insights into NFB regulation and function. Trends Immunol. 29, 469-478
69. Klamer, G., Song, E., Ko, K. H., O'Brien, T. A., and Dolnikov, A. (2010) Using small molecule GSK3-inhibitors to treat inflammation. Curr. Med. Chem. 17, 2873-2881
70. Cartharius, K., Frech, K., Grote, K., Klocke, B., Haltmeier, M., Klingenhoff, A., Frisch, M., Bayerlein, M., and Werner, T. (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21, 2933-2942
71. Kim, C. G., Chung, I. Y., Lim, Y., Lee, Y. H., and Shin, S. Y. (2011) A Tcf/Lef element within the enhancer region of the human NANOG gene plays a role in promoter activation. Biochem. Biophys. Res. Commun. 410, 637-642
72. Kluve-Beckerman, B., Drumm, M. L., and Benson, M. D. (1991) Nonexpression of the human serum amyloid A three (SAA3) gene. DNA Cell Biol. 10, 651-661